Exhibit 10.6


 





PRIVATE
PLACEMENT WARRANTS PURCHASE AGREEMENT


 


THIS
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of March 4, 2021 (as it may from time to time be amended, this “Agreement”),
is entered into by and between Tribe Capital Growth Corp I, a Delaware corporation (the “Company”) and Cantor
Fitzgerald & Co., a New York general partnership and representative of the underwriters in the Public Offering (as described
below) (the “Purchaser”).


 


WHEREAS:


 


The
Company intends to consummate an initial public offering of the Company’s units (the “Public Offering”),
each unit (each a “Unit”) consisting of one share of Class A common stock of the Company, par value $0.0001
per share (each, a “Share”), and one-fourth of one redeemable warrant;


 


Each
whole warrant entitles the holder to purchase one Share at an exercise price of $11.50 per Share;


 


The
Purchaser has agreed to purchase an aggregate of 755,555 warrants (or 835,555 warrants if the over-allotment option is exercised
in full) at a price of $1.50 per warrant (the “Private Placement Warrants”), each Private Placement Warrant
entitling the holder to purchase one Share at an exercise price of $11.50 per Share; and


 


Concurrently
with the execution of this Agreement, the Company is entering into that certain Private Placement Warrants Purchase Agreement,
dated as of the date hereof, with Tribe Arrow Holdings I LLC (the “Sponsor”), pursuant to which the Sponsor
has agreed to purchase an aggregate of 3,777,778 warrants (or up to 4,177,778 warrants if the Purchaser exercises its over-allotment
option to purchase additional Units in full).


 


NOW
THEREFORE, in consideration of the mutual promises contained in this Agreement and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound,
agree as follows:


 


AGREEMENT


 


Section 1. 
Authorization, Purchase and Sale; Terms of the Private Placement Warrants.


 


A.  Authorization
of the Private Placement Warrants.  The Company has duly authorized the issuance and sale of the Private Placement Warrants
to the Purchaser.


 


B.  Purchase
and Sale of the Private Placement Warrants.


 


(i)           Simultaneously with the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the
Purchaser and the Company (the “Initial Closing Date”), the Company shall issue and sell to the Purchaser,
and the Purchaser shall purchase from the Company, an aggregate of 755,555 Private Placement Warrants at a price of $1.50 per
warrant for an aggregate purchase price of $1,133,332.50 (the “Purchase Price”). Purchaser shall pay the Purchase
Price by wire transfer of immediately available funds to the trust account (the “Trust Account”) maintained
by Continental Stock Transfer & Trust Company, acting as trustee (”Continental”), on the Initial Closing
Date.  On the Initial Closing Date, upon the payment by the Purchaser of the Purchase Price, the Company, at its option,
shall deliver a certificate evidencing the Private Placement Warrants purchased on such date duly registered in the Purchaser’s
name to the Purchaser or effect such delivery in book-entry form. 


 


(ii)          Simultaneously with the consummation of the closing of the over-allotment option in connection with the Public Offering (the “Over-Allotment
Option”) or on such earlier time and date as may be mutually agreed by the Purchaser and the Company (each such date,
an “Over-Allotment Closing Date,” and each Over-Allotment Closing Date (if any) and the Initial Closing Date
being sometimes referred to herein as a “Closing Date”), Purchaser shall purchase up to an additional 80,000
Private Placement Warrants (the “Additional Warrants”), in the same proportion as the amount of the option
that is so exercised, and simultaneously with such purchase of Additional Warrants, as payment in full for the Additional Warrants
being purchased hereunder, on the Over-Allotment Closing Date, Purchaser shall pay $1.50 per Additional Warrant, up to an aggregate
amount of $120,000 (the “Over-Allotment Purchase Price”), by wire transfer of immediately available funds or
by such other method as may be reasonably acceptable to the Company, to the Trust Account. On the Over-Allotment Closing Date,
upon the payment by the Purchaser of the Over-Allotment Purchase Price, the Company, at its option, shall deliver a certificate
evidencing the Additional Warrants purchased on such date duly registered in the Purchaser’s name to the Purchaser or effect
such delivery in book-entry form. 





     


     

    



C.  Terms
of the Private Placement Warrants.


 


(i) 
Each Private Placement Warrant shall have the terms set forth in a Warrant Agreement to be entered into by the Company and Continental
in connection with the Public Offering (the “Warrant Agreement”). Such terms include the fact that the Private
Placement Warrants shall not be transferable, assignable or salable until 30 days after the completion of an initial business
combination, subject to certain exceptions set forth in the Warrant Agreement.


 


(ii) 
On or prior to the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement (the “Registration
Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating to
the Private Placement Warrants and the Shares underlying the Private Placement Warrants.


 


(iii)
FINRA Requirements. Notwithstanding Section 1(C)(i) above, the Purchaser further acknowledges and agrees that the Private
Placement Warrants and the Shares underlying Private Placement Warrants will be deemed compensation by the Financial Industry
Regulatory Authority (“FINRA”) and will therefore, pursuant to Rule 5110(e)(1) of the FINRA Manual, be subject
to a lock-up for a period of 180 days immediately following the commencement of sales of the Public Offering. The Private Placement
Warrants and Shares underlying the Private Placement Warrants may not be sold, transferred, assigned, pledged or hypothecated
or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition
of such securities by any person during the foregoing 180-day period except as permitted in accordance with FINRA Rule 5110(e)(2)(B).  


 


Section 2. 
Representations and Warranties of the Company.  As a material inducement to the Purchaser to enter into this Agreement
and purchase the Private Placement Warrants, the Company hereby represents and warrants to the Purchaser (which representations
and warranties shall survive the Closing Date) that:


 


A.  Incorporation
and Corporate Power.  The Company is a corporation duly incorporated, validly existing and in good standing under the
laws of the State of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably
be expected to have a material adverse effect on the financial condition, operating results or assets of the Company.  The
Company possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement
and the Warrant Agreement.


 


B.  Authorization;
No Breach.


 


(i) 
The execution, delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized by the
Company as of the Closing Date.  This Agreement constitutes the valid and binding obligation of the Company, enforceable
in accordance with its terms.  Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement
and this Agreement, the Private Placement Warrants will constitute valid and binding obligations of the Company, enforceable in
accordance with their terms.


 


(ii) 
The execution and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private
Placement Warrants, the issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment, of and compliance
with, the respective terms hereof and thereof by the Company, do not and will not as of the Closing Date (a) conflict with
or result in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation
of any lien, security interest, charge or encumbrance upon the Company’s share capital or assets under, (d) result
in a violation of, or (e) require any authorization, consent, approval, exemption or other action by or notice or declaration
to, or filing with, any court or administrative or governmental body or agency pursuant to the amended and restated certificate
of incorporation of the Company (in effect on the date hereof or as may be amended prior to completion of the contemplated Public
Offering), or any material law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment
or decree to which the Company is subject, except for any filings required after the date hereof under federal or state securities
laws.




     


     

    

C.  Title
to Securities.  Upon issuance in accordance with, and payment pursuant to, the terms hereof, the Warrant Agreement, the
Shares issuable upon exercise of the Private Placement Warrants will be duly and validly issued as fully paid and nonassessable.
On the date of issuance of the Private Placement Warrants, the Shares issuable upon exercise of the Private Placement Warrants
shall have been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant
Agreement, the Purchaser will have good title to the Private Placement Warrants and the Shares issuable upon exercise of such
Private Placement Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions
hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under federal and state securities
laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.


 


D. Valid
Issuance. The total number of shares of all classes of capital stock which the Company has authority to issue is 301,000,000
shares of common stock (which consist of 280,000,000 shares of the Company’s Class A Common Stock and 20,000,000 shares
of the Company’s Class B common stock, par value $0.0001 per share (the “Class B Common Stock”)) and 1,000,000
shares of the Company’s preferred stock, par value $0.0001 per share (the “Preferred Stock”). As of the date
hereof, the Company has issued and outstanding no shares of Class A Common Stock, 6,900,000 shares of Class B Common Stock (of
which up to 900,000 shares are subject to forfeiture as described in the registration statement relating to the Public Offering
(the “Registration Statement”)) and no shares of Preferred Stock. All of the issued shares of capital stock
of the Company have been duly authorized, validly issued, and are fully paid and non-assessable. 


 


E.  Governmental
Consents.  No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority
is required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by
the Company of any other transactions contemplated hereby.


 


Section 3. 
Representations and Warranties of the Purchaser.  As a material inducement to the Company to enter into this Agreement
and issue and sell the Private Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company
(which representations and warranties shall survive the Closing Date) that:


 


A.  Organization
and Requisite Authority.  The Purchaser possesses all requisite power and authority necessary to carry out the transactions
contemplated by this Agreement.


 


B.  Authorization;
No Breach.


 


(i) 
This Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject
to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating
to or affecting creditors’ rights and to general equitable principles (whether considered in a proceeding in equity or law).


 


(ii) 
The execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the
Purchaser does not and shall not as of the Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions
or provisions of any agreement, instrument, order, judgment or decree to which the Purchaser is subject.




     


     

    

C.  Investment
Representations.


 


(i) 
The Purchaser is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable
upon such exercise (collectively, the “Securities”), for the Purchaser’s own account, for investment
purposes only and not with a view towards, or for resale in connection with, any public sale or distribution thereof.


 


(ii) 
The Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D under
the Securities Act of 1933, as amended (the “Securities Act”).


 


(iii) 
The Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from
the registration requirements of the United States federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth
herein in order to determine the availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.


 


(iv) 
The Purchaser did not enter into this Agreement as a result of any general solicitation or general advertising within the meaning
of Rule 502(c) under the Securities Act.


 


(v) 
The Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials
relating to the offer and sale of the Securities which have been requested by the Purchaser.  The Purchaser has been afforded
the opportunity to ask questions of the executive officers and directors of the Company.  The Purchaser understands that
its investment in the Securities involves a high degree of risk and it has sought such accounting, legal and tax advice as it
has considered necessary to make an informed investment decision with respect to the acquisition of the Securities.


 


(vi) 
The Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed
on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities
by the Purchaser nor have such authorities passed upon or endorsed the merits of the offering of the Securities.


 


(vii) 
The Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or
any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered
thereunder or (2) sold in reliance on an exemption therefrom; and (b) except as specifically set forth in the Registration
Rights Agreement, neither the Company nor any other person is under any obligation to register the Securities under the Securities
Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder.  The Private Placement
Warrants will bear a legend and appropriate “stop transfer” instructions (or an appropriate notation if the warrants
are issued in book entry form) relating to the foregoing. The Purchaser further understands that the Securities and Exchange Commission
(the “SEC”) has taken the position that promoters or affiliates of a blank check company and their transferees,
both before and after an initial business combination, are deemed to be “underwriters” under the Securities Act when
reselling the securities of a blank check company.  Based on that position, Rule 144 adopted pursuant to the Securities
Act would not be available for resale transactions of the Securities until the one-year anniversary following consummation of
an initial business combination despite technical compliance with the requirements of such Rule.


 


(viii) 
The Purchaser has such knowledge and experience in financial and business matters, knows of the high degree of risk associated
with investments in the securities of companies in the development stage such as the Company, is capable of evaluating the merits
and risks of an investment in the Securities and is able to bear the economic risk of an investment in the Securities in the amount
contemplated hereunder for an indefinite period of time.  The Purchaser has adequate means of providing for its current financial
needs and contingencies and will have no current or anticipated future needs for liquidity which would be jeopardized by the investment
in the Securities.  The Purchaser can afford a complete loss of its investment in the Securities.




     


     

    

Section 4. 
Conditions of the Purchaser’s Obligations.  The obligations of the Purchaser to purchase and pay for the Private
Placement Warrants are subject to the fulfillment, on or before the Closing Date, of each of the following conditions:


 


A.  Representations
and Warranties.  The representations and warranties of the Company contained in Section 2 shall be true and correct
at and as of such Closing Date as though then made.


 


B.  Performance. 
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by it on or before such Closing Date.


 


C.  No
Injunction.  No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been
enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory
organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Warrant Agreement.


 


D.  Warrant
Agreement.  The Company shall have entered into the Warrant Agreement.


 


Section 5. 
Conditions of the Company’s Obligations.  The obligations of the Company to the Purchaser under this Agreement
are subject to the fulfillment, on or before the Closing Date, of each of the following conditions:


 


A.  Representations
and Warranties.  The representations and warranties of the Purchaser contained in Section 3 shall be true and correct
at and as of such Closing Date as though then made.


 


B.  Performance. 
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by the Purchaser on or before such Closing Date.


 


C.  No
Injunction.  No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been
enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory
organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Warrant Agreement.


 


D.  Warrant
Agreement.  The Company shall have entered into the Warrant Agreement.


 


Section 6. 
Termination.  This Agreement may be terminated at any time after June 30, 2021 upon the election by either the Company
or the Purchaser solely as to itself upon written notice to the other party if the closing of the Public Offering does not occur
prior to such date.


 


Section 7. 
Survival of Representations and Warranties.  All of the representations and warranties contained herein shall survive
the Closing Date.


 


Section 8. 
Definitions.  Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in
the Registration Statement.


 


Section 9. 
Miscellaneous.


 


A.  Successors
and Assigns.  Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement
by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto
whether so expressed or not.  Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign
this Agreement without the prior written consent of the other party hereto, other than assignments by the Purchaser to affiliates
thereof.


 


B.  Severability. 
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall
be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.




     


     

    

C.  Counterparts. 
This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than
one party, but all such counterparts taken together shall constitute one and the same agreement.


 


D.  Descriptive
Headings; Interpretation.  The descriptive headings of this Agreement are inserted for convenience only and do not constitute
a substantive part of this Agreement.  The use of the word “including” in this Agreement shall be by way
of example rather than by limitation.


 


E.  Governing
Law.  This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes
shall be construed in accordance with the internal laws of the State of New York, without regard to the conflicts of laws principles
thereof.


 


F.  Amendments. 
This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed
by all parties hereto.


 


[Signature
page follows]






     


     

    

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of the date first set forth above.


 


	 	COMPANY:
	 	 
	 	TRIBE
    CAPITAL GROWTH CORP I 
	 	 
	 	By:	/s/Arjun
    Sethi 
	 	 	Name:	 Arjun Sethi
	 	 	Title:	 Chief Executive Officer
	 	 
	 	PURCHASER:
	 	 
	 	CANTOR
    FITZGERALD & CO.
	 	 
	 	By:	/s/David
    Batalion
	 	 	Name:	 David Batalion
	 	 	Title:	 Managing Director


   


[Signature
page to Private Placement Warrants Purchase Agreement]